When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Tocilizumab - Wikipedia

   en.wikipedia.org/wiki/Tocilizumab

   Tocilizumab, sold under the brand name Actemra among others, is an immunosuppressive drug, used for the treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, giant cell arteritis, cytokine release syndrome, COVID‑19, and systemic sclerosis-associated interstitial lung disease ...

3. Disease-modifying antirheumatic drug - Wikipedia

   en.wikipedia.org/wiki/Disease-modifying_anti...

   Although the use of the term DMARDs was first propagated in rheumatoid arthritis (hence their name), the term has come to pertain to many other diseases, such as Crohn's disease, lupus erythematosus, Sjögren syndrome, immune thrombocytopenic purpura, myasthenia gravis, sarcoidosis, and various others.

4. Anti-interleukin-6 - Wikipedia

   en.wikipedia.org/wiki/Anti-interleukin-6

   The first approved medication in this class, tocilizumab (Actemra), is an antibody directed against the IL6-receptor. [8] The second, siltuximab (Sylvant), is directed against IL-6 itself. [ 1 ] [ 9 ] Siltuximab is approved for treatment of human immunodeficiency virus-negative and HHV-8 -negative patients with multicentric Castleman's disease .

5. FDA Approves ACTEMRA® for Children Living with a Rare ... - AOL

   www.aol.com/2013/04/30/fda-approves-actemra-for...

   FDA Approves ACTEMRA ® for Children Living with a Rare Form of Arthritis Medicine Offers a New Option for the Treatment of Polyarticular Juvenile Idiopathic Arthritis (PJIA) SOUTH SAN FRANCISCO ...

6. FDA Approves Expanded Indication for ACTEMRA® in ... - AOL

   www.aol.com/news/2012-10-12-fda-approves...

   FDA Approves Expanded Indication for ACTEMRA ® in Rheumatoid Arthritis SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Genentech, Inc., a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY ...

7. Roche settles US patent lawsuit against Biogen over ...

   www.aol.com/news/roche-settles-us-patent-lawsuit...

   Actemra sales were down 22% from 2021 based on decreased demand for the drug as a COVID-19 treatment. The U.S. Food and Drug Administration last month approved Biogen's Tofidence, the first ...